Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02604537 · ClinicalTrials.gov registry record · Phase 4
Betamethasone Versus Ketorolac Injection for the Treatment of DeQuervains Tenosynovitis
A Phase 4 study, sponsored by OrthoCarolina Research Institute.
- Completed
- Registry status
- Phase 4
- Development phase
- 62
- Enrollment target
NCT02604537 is a Phase 4 study that has completed, run by OrthoCarolina Research Institute. The registered enrollment target is 62 participants.
The verdict
NCT02604537, a Phase 4 study, has completed, sponsored by OrthoCarolina Research Institute.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 62 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if corticosteroid injection modifies the natural course of de Quervain tendinopathy compared to a toradol injection.
Interventions
- DRUG Ketorolac
- DRUG betamethasone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2015-10-15 |
| Est. Completion | 2024-10-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02604537
The ClinicalTrials.gov registry entry for NCT02604537 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is OrthoCarolina Research Institute, which has 28 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ketorolac is the first listed.
NCT02604537 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02604537 about?
NCT02604537 is a clinical study titled "Betamethasone Versus Ketorolac Injection for the Treatment of DeQuervains Tenosynovitis". The purpose of this study is to determine if corticosteroid injection modifies the natural course of de Quervain tendinopathy compared to a toradol injection.
What is the current status of trial NCT02604537?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 62 participants. The study started on 2015-10-15. Estimated completion is 2024-10-30.
What interventions are being tested in trial NCT02604537?
The interventions under investigation include: Ketorolac (DRUG), betamethasone (DRUG).
Who is sponsoring clinical trial NCT02604537?
This trial is sponsored by OrthoCarolina Research Institute, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.